Methicillin-resistant Staphylococcus aureus infections.

Abraham R Taylor
Author Information
  1. Abraham R Taylor: Department of Family and Community Medicine, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA. ataylor3@hmc.psu.edu

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly common multidrug-resistant clinical pathogen responsible for increasing health costs and for patient morbidity and mortality. Presented in this review, the definition, cell and molecular biology, epidemiology, prevention, diagnosis, and treatment of MRSA infections, including skin and soft tissue infections, bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system infections, are addressed. In the treatment of MRSA, this article highlights several common antibiotics that retain activity against different strains of MRSA.

Keywords

MeSH Term

Abscess
Anti-Bacterial Agents
Bacteremia
Endocarditis
Humans
Methicillin-Resistant Staphylococcus aureus
Pneumonia
Primary Health Care
Risk Factors
Staphylococcal Infections
United States

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0MRSAinfectionsMethicillin-resistantStaphylococcusaureuscommontreatmentincreasinglymultidrug-resistantclinicalpathogenresponsibleincreasinghealthcostspatientmorbiditymortalityPresentedreviewdefinitioncellmolecularbiologyepidemiologypreventiondiagnosisincludingskinsofttissuebacteremiaendocarditispneumoniabonejointcentralnervoussystemaddressedarticlehighlightsseveralantibioticsretainactivitydifferentstrainsAntibiotic-resistantReview

Similar Articles

Cited By